Veterinary Pain Management Market Report 2026

Veterinary Pain Management Market Overview

• Veterinary Pain Management market size has reached to $2.32 billion in 2025 • Expected to grow to $3.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Impact Of Rising Pet Ownership On The Veterinary Pain Management Market • Market Trend: Electronic Prescription And Delivery Platforms Enhancing Pain Management Access • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Pain Management Market?

Veterinary pain management refers to a method that uses medicines and related products to support healing and recovery and to identify and treat the underlying condition to maintain the quality of health of an animal. It is used to enhance the quality of life for pets and livestock, ensuring comfort during and after surgery or due to chronic conditions. The main products in veterinary pain management are drugs and devices. Drugs refer to anything (apart from food) that is used to cure or relieve the symptoms of an illness or other abnormal state. The different types of animals include companion animals and livestock and involve several distributed channels such as hospitals and clinics and pharmacy channels. It is are used in joint pain, postoperative pain, cancer, and other applications.

What Is The Veterinary Pain Management Market Growth Forecast?

The veterinary pain management market size is expected to see rapid growth in the next few years. It will grow to $3.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to advancements in veterinary analgesics, development of smart pain management devices, increasing awareness of animal welfare, rise in geriatric pet population, growth of livestock healthcare programs. Major trends in the forecast period include personalized pain management solutions, minimally invasive pain management techniques, growth in postoperative care services for animals, rising awareness of animal welfare and comfort, integration of wearable monitoring devices in veterinary care.

What Is The Driver Of The Veterinary Pain Management Market?

Rising pet ownership is expected to propel the veterinary pain management market going forward. Pet ownership is the act of owning or possessing a domestic animal, such as a dog, cat, or other pet. Pet ownership is rising because more people seek companionship and emotional support from animals, which provides comfort and reduces feelings of loneliness in daily life. Veterinary pain management helps pet ownership by ensuring pets remain healthy, comfortable, and active, which strengthens the bond between owners and their animals. For instance, in 2023, according to the Shelter Animals Count, a US-based non-governmental organization, in 2023, Shelter Animals Count estimates 6.5 million cats and dogs entered shelters and rescues across America. Therefore, rising pet ownership is driving the demand for the veterinary pain management industry.

Key Players In The Global Veterinary Pain Management Market

Major companies operating in the veterinary pain management market are CH Boehringer Sohn AG & Co. KG, Zoetis Inc., Merck & Co Inc., Elanco Animal Health Incorporated, Ceva Santé Animale, Vetoquinol SA, Norbrook Laboratories Inc., Dechra Pharmaceuticals PLC, Chanelle Pharmaceuticals Manufacturing Ltd., Assisi Animal Health, Bayer AG, Eli Lilly and Company, Novartis AG, SeQuent Scientific Limited, Eltech K-Laser srl, Virbac, Durvet Inc., Bimeda Inc., Inovet Pharma (A subsidiary of Orion Group), Zenex Animal Health India Private Ltd., AnimalCare Group PLC, Eco Animal Health Group PLC, Prodivet pharmaceuticals S. A., Henry Schein Inc., Covetrus Inc., MWI Veterinary Supply Inc., Animal Health International Inc., Midwest Veterinary Supply Inc.

Global Veterinary Pain Management Market Trends and Insights

Major companies operating in the veterinary pain management market are focusing on technological advancements, such as Tractor Supply RX, to gain a competitive advantage. Tractor Supply RX is an electronic prescription and delivery platform that enables veterinarians to issue, transmit, and manage prescriptions for pain management therapeutics digitally while connecting with fulfillment services to deliver prescribed analgesics directly to clients within a prescription delivery service framework, improving access, convenience, and adherence to treatment protocols. For instance, in April 2025, Tractor Supply Company, a US-based rural lifestyle retailer, launched Tractor Supply RX, offering integrated online ordering of prescribed pain and other medications, automatic delivery via its AutoShip program, and expert pharmacist support to assist customers with medication needs and dosing guidance. This innovation broadens access, enhances client engagement, and supports continuity of care but requires careful alignment with veterinary clinical processes and compliance with regulatory standards.

What Are Latest Mergers And Acquisitions In The Veterinary Pain Management Market?

In September 2024, Boehringer Ingelheim International GmbH, a Germany based provider of human and animal health pharmaceuticals, biologics, and therapeutic solutions, acquired Saiba Animal Health AG for an undisclosed amount. With this acquisition, Boehringer Ingelheim strategically enhanced its animal health research and development pipeline by integrating Saiba’s innovative therapeutic vaccine technologies that target chronic diseases, including inflammation and pain, thereby strengthening its veterinary pain management and pet therapeutics portfolio. Saiba Animal Health AG is a Switzerland based developer of novel therapeutic medicines for companion animals, focusing on virus like particle based vaccines designed to address chronic conditions such as allergy, inflammation, and pain.

What Defines the Veterinary Pain Management Market?

The veterinary pain management market consists of revenues earned by entities by anesthetics, opioids, nonsteroidal anti-inflammatory drugs (NSIDs), alpha-2 agonists, and disease-modifying osteoarthritis agents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market consists of sales of laser therapy devices and electromagnetic therapy devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Veterinary Pain Management Market Report 2026?

The veterinary pain management market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pain management industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.